Gsk Stock Quote GSK - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1,405.00

Bid

1,406.00

Ask

1,406.50

Volume

13,745,946

1,399.50 Day's Range 1,410.50

1,282.50 52 Week Range 1,820.00

Market Cap

58.239B

Previous Close

1,402.00

Open

1,404.00

Last Trade

1404.5

(O)

Last Trade Time

Financial Volume

193,098,568p

VWAP

1,404.7674

Average Volume (3m)

7,581,468

Shares Outstanding

4,145,132,579

Dividend Yield

4.27%

PE Ratio

11.83

Earnings Per Share (EPS)

1.19

Revenue

30.33B

Net Profit

4.93B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gsk.com

Headquarters

London, Gbr

Founded

Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,402p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,132,579 shares outstanding. The market capitalization of Gsk is £58.11 billion. Gsk has a price to earnings ratio (PE ratio) of 11.83.

GSK applications for sinus disease treatment accepted for review

GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal pol ...

GSK PLC Depemokimab dual filing in China and Japan

GSK PLC 28 January 2025 Issued: 28 January 2025 London UK Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP · If approved...

GSK PLC EMA accepts two submissions for depemokimab

GSK PLC 28 January 2025 Issued: 28 January 2025 London UK Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP · If...

GSK and University of Oxford researchers to create cancer vaccine

Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease fro ...

GSK shingles treatment application accepted for review in Europe

GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment ...

GSK PLC EMA accept review Shingrix syringe presentation

GSK PLC 27 January 2025 Issued: 27 January 2025, London UK GSK's Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency · If approved, the new...

GSK gets EU nod for expanded use of Jemperli in endometrial cancer

GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemo ...

GSK applications for sinus disease treatment accepted for review

GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal pol ...

GSK PLC Depemokimab dual filing in China and Japan

GSK PLC 28 January 2025 Issued: 28 January 2025 London UK Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP · If approved...

GSK PLC EMA accepts two submissions for depemokimab

GSK PLC 28 January 2025 Issued: 28 January 2025 London UK Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP · If...

GSK and University of Oxford researchers to create cancer vaccine

Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease fro ...

GSK shingles treatment application accepted for review in Europe

GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment ...

GSK PLC EMA accept review Shingrix syringe presentation

GSK PLC 27 January 2025 Issued: 27 January 2025, London UK GSK's Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency · If approved, the new...

GSK gets EU nod for expanded use of Jemperli in endometrial cancer

GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemo ...

GSK PLC Jemperli expanded approval in the EU

GSK PLC 20 January 2025 Issued: 20 January 2025, London UK European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or...

GSK PLC Director/PDMR Shareholding

GSK PLC 16 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name David Redfern b) Position/status President...

GSK PLC Director/PDMR Shareholding

GSK PLC 15 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	40	2.9304029304	1365	1416	1353	8729313	1393.3486865	DE
4	41.5	3.0436376971	1363.5	1416	1289	7004837	1360.73495589	DE
12	9	0.644699140401	1396	1416	1282.5	7581468	1345.97470872	DE
26	-131	-8.52864583333	1536	1678	1282.5	7620240	1447.10521048	DE
52	-130	-8.46905537459	1535	1820	1282.5	7787768	1545.16610754	DE
156	-266.2	-15.9286740067	1671.2	1824.4	1282.5	8542991	1518.3052275	DE
260	-388	-21.6397099833	1793	1847	1190.8	8758548	1499.54491501	DE

GSK - Frequently Asked Questions (FAQ)

What is the current Gsk share price?

The current share price of Gsk is 1,405.00p

How many Gsk shares are in issue?

Gsk has 4,145,132,579 shares in issue

What is the market cap of Gsk?

The market capitalisation of Gsk is GBP 58.11B

What is the 1 year trading range for Gsk share price?

Gsk has traded in the range of 1,282.50p to 1,820.00p during the past year

What is the PE ratio of Gsk?

The price to earnings ratio of Gsk is 11.83

What is the cash to sales ratio of Gsk?

The cash to sales ratio of Gsk is 1.92

What is the reporting currency for Gsk?

Gsk reports financial results in GBP

What is the latest annual turnover for Gsk?

The latest annual turnover of Gsk is GBP 30.33B

What is the latest annual profit for Gsk?

The latest annual profit of Gsk is GBP 4.93B

What is the registered address of Gsk?

The registered address for Gsk is 79 NEW OXFORD STREET, LONDON, WC1A 1DG

What is the Gsk website address?

The website address for Gsk is www.gsk.com

Which industry sector does Gsk operate in?

Gsk operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AIQAiq Limited	4.00p (33.33%)	37.88k
INSPInspirit Energy Holdings Plc	0.0036p (28.57%)	1.43B
ALKAlkemy Capital Investments Plc	175.00p (27.27%)	176.27k
KNBKanabo Group Plc	1.00p (25.00%)	461.04k
TCFTheracryf Plc	1.125p (25.00%)	6.72M
MET1Metals One Plc	0.275p (-35.29%)	16.2M
PPSProton Motor Power Systems Plc	0.175p (-22.22%)	848.7k
SYMESupply@me Capital Plc	0.0025p (-19.35%)	372.49M
CGNRConroy Gold & Natural Resources Plc	2.15p (-18.87%)	739.53k
ONCOncimmune Holdings Plc	10.40p (-16.47%)	1.19M
INSPInspirit Energy Holdings Plc	0.0036p (28.57%)	1.43B
NTVONativo Resources Plc	0.0018p (-5.26%)	1.41B
MSMNMosman Oil And Gas Limited	0.041p (10.81%)	1.22B
TRPTower Resources Plc	0.0295p (0.00%)	691.76M
SYMESupply@me Capital Plc	0.0025p (-19.35%)	372.49M